Artículos de revistas sobre el tema "Eμ-TCL1 mice"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Eμ-TCL1 mice".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Gobessi, Stefania, Francesca Belfiore, Sara Bennardo, Brendan Doe, Luca Laurenti y Dimitar G. Efremov. "Expression of ZAP-70 Does Not Accelerate Leukemia Development and Progression in the Eμ-TCL1 Transgenic Mouse Model of Chronic Lymphocytic Leukemia". Blood 120, n.º 21 (16 de noviembre de 2012): 925. http://dx.doi.org/10.1182/blood.v120.21.925.925.
Texto completoLarsson, Connie A., Kensuke Kojima, Yong Wang, Nicholas Navin, Miguel Gallardo, Daniel Primo, Jose L. Rojas et al. "BET Bromodomain Inhibition Reduces Leukemic Burden and Prolongs Survival In The Eμ-TCL1 Transgenic Mouse Model Of Chronic Lymphocytic Leukemia (CLL) Independent Of TP53 Mutation Status". Blood 122, n.º 21 (15 de noviembre de 2013): 876. http://dx.doi.org/10.1182/blood.v122.21.876.876.
Texto completoBennardo, Sara, Stefano Iacovelli, Stefania Gobessi, Mirza Suljagic, Daniel Bilbao, Julia Eckl-Dorna, Hongsheng Wang et al. "The Nature of the Antigen Determines Leukemia Development and Behavior in the Eμ-TCL1 Transgenic Mouse Model of CLL". Blood 120, n.º 21 (16 de noviembre de 2012): 181. http://dx.doi.org/10.1182/blood.v120.21.181.181.
Texto completoWu, Qingli, Zierold Claudia y Erik A. Ranheim. "Dysregulation of Frizzled 6 Is a Critical Component of B Cell Leukemogenesis in a Mouse Model of Chronic Lymphocytic Leukemia." Blood 110, n.º 11 (16 de noviembre de 2007): 347. http://dx.doi.org/10.1182/blood.v110.11.347.347.
Texto completoBellone, Matteo, Paolo Dellabona, Arianna Calcinotto, Giulia Casorati, Alessandra Rovida, Maria Teresa Sabrina Bertilaccio, Elena Cattaneo, Matteo Grioni, Federico caligaris-Cappio y Paolo Ghia. "CD4+ T Cells Sustain Aggressive Chronic Lymphocytic Leukemia through a CD40L-Independent Mechanism". Blood 134, Supplement_1 (13 de noviembre de 2019): 683. http://dx.doi.org/10.1182/blood-2019-128246.
Texto completoAlhakeem, Sara S., Mary K. McKenna, Sunil K. Nooti, Karine Z. Oben, Vivek M. Rangnekar, John C. Byrd, Natarajan Muthusamy y Subbarao Bondada. "Suppression of Anti-Tumor Immunity in Chronic Lymphocytic Leukemia Via Interleukin-10 Production". Blood 128, n.º 22 (2 de diciembre de 2016): 3215. http://dx.doi.org/10.1182/blood.v128.22.3215.3215.
Texto completoMcKenna, Mary Kathryn, Sunil K. Nooti, Sara Samir Alhakeem, Beth W. Gachuki, Frank Frissora, Joseph T. Greene, John C. Byrd, Natarajan Muthusamy, Vivek R. Rangnekar y Subbarao Bondada. "Role of Prostate apoptosis response-4 tumor suppressor in the survival and growth of Chronic Lymphocytic Leukemia". Journal of Immunology 196, n.º 1_Supplement (1 de mayo de 2016): 72.15. http://dx.doi.org/10.4049/jimmunol.196.supp.72.15.
Texto completoMcClanahan, Fabienne, Cristina Ghirelli, Paul Greaves, John C. Riches, Rita Coutinho, Alan G. Ramsay y John G. Gribben. "Inhibitory Ligands CD200, CD270, CD274 and CD276 Are Expressed On Eμ-TCL1 Transgenic Mouse Splenocytes and Are of Potential Relevance to Impaired T-Cell Function in Vivo". Blood 120, n.º 21 (16 de noviembre de 2012): 313. http://dx.doi.org/10.1182/blood.v120.21.313.313.
Texto completoKriss, Crystina L., Javier A. Pinilla-Ibarz, Adam W. Mailloux, John J. Powers, Chih-Hang Anthony Tang, Chang Won Kang, Nicola Zanesi et al. "Overexpression of TCL1 activates the endoplasmic reticulum stress response: a novel mechanism of leukemic progression in mice". Blood 120, n.º 5 (2 de agosto de 2012): 1027–38. http://dx.doi.org/10.1182/blood-2011-11-394346.
Texto completoEnzler, Thomas, Arnon P. Kater, Weizhou Zhang, George F. Widhopf, Han-Yu Chuang, Jason Lee, Esther Avery, Carlo M. Croce, Michael Karin y Thomas J. Kipps. "Chronic lymphocytic leukemia of Eμ-TCL1 transgenic mice undergoes rapid cell turnover that can be offset by extrinsic CD257 to accelerate disease progression". Blood 114, n.º 20 (12 de noviembre de 2009): 4469–76. http://dx.doi.org/10.1182/blood-2009-06-230169.
Texto completoNganga, Vincent K., Victoria L. Palmer, Hina Naushad, Michele D. Kassmeier, Dirk K. Anderson, Greg A. Perry, Nathan M. Schabla y Patrick C. Swanson. "Accelerated progression of chronic lymphocytic leukemia in Eμ-TCL1 mice expressing catalytically inactive RAG1". Blood 121, n.º 19 (9 de mayo de 2013): 3855–66. http://dx.doi.org/10.1182/blood-2012-08-446732.
Texto completoGrioni, Matteo, Arianna Brevi, Elena Cattaneo, Alessandra Rovida, Jessica Bordini, Maria Teresa Sabrina Bertilaccio, Maurilio Ponzoni et al. "CD4+ T cells sustain aggressive chronic lymphocytic leukemia in Eμ-TCL1 mice through a CD40L-independent mechanism". Blood Advances 5, n.º 14 (16 de julio de 2021): 2817–28. http://dx.doi.org/10.1182/bloodadvances.2020003795.
Texto completoWu, Qingli y Erik A. Ranheim. "Upregulation of Genes Involved in the Beta-Catenin Signaling Pathway in a Mouse Model of Chronic Lymphocytic Leukemia." Blood 104, n.º 11 (16 de noviembre de 2004): 1121. http://dx.doi.org/10.1182/blood.v104.11.1121.1121.
Texto completoRamsay, Alan G., Gullu Gorgun, Tobias A. W. Holderried, David Zahrieh, Fenglong Liu, John Quackenbush, Carlo M. Croce y John G. Gribben. "A Mouse Model for Immunotherapeutic Reversal of Leukemia-Induced T Cell Dysfunction". Blood 112, n.º 11 (16 de noviembre de 2008): 30. http://dx.doi.org/10.1182/blood.v112.11.30.30.
Texto completoReinart, Nina, Malgorzata Ciesla, Cornelia Rudolph, Astrid Stein, Guenter Krause, Brigitte Schlegelberger, Michael Hallek y Guenter Fingerle-Rowson. "Macrophage Migration Inhibitory Factor (MIF) Promotes the Development of Murine Chronic Lymphocytic Leukemia (CLL)". Blood 112, n.º 11 (16 de noviembre de 2008): 27. http://dx.doi.org/10.1182/blood.v112.11.27.27.
Texto completoScielzo, Cristina, Maria T. S. Bertilaccio, Giorgia Simonetti, Antonis Dagklis, Elisa ten Hacken, Claudia Fazi, Marta Muzio et al. "HS1 has a central role in the trafficking and homing of leukemic B cells". Blood 116, n.º 18 (4 de noviembre de 2010): 3537–46. http://dx.doi.org/10.1182/blood-2009-12-258814.
Texto completoFerrer, Gerardo, Xiao-Jie Yan, Brendan Franca, Jacqueline C. Barrientos, Jonathan E. Kolitz, Steven L. Allen, Kanti R. Rai y Nicholas Chiorazzi. "Chronic Lymphocytic Leukemia Patients and Eµ-TCL1 Mice Share a Phenotype of Functional Granulocyte-like and Dysfunctional Monocyte-like Myeloid Derived Suppressor Cells". Blood 126, n.º 23 (3 de diciembre de 2015): 614. http://dx.doi.org/10.1182/blood.v126.23.614.614.
Texto completoAlhakeem, Sara Samir, Mary Kathryn McKenna, Beth W. Gachuki, Vivek R. Rangnekar, John C. Byrd, Natarajan Muthusamy y Subbarao Bondada. "The role of IL-10 in B-cell chronic lymphocytic leukemia cell survival". Journal of Immunology 196, n.º 1_Supplement (1 de mayo de 2016): 211.17. http://dx.doi.org/10.4049/jimmunol.196.supp.211.17.
Texto completoEnzler, Thomas, Weizhou Zhang, Arnon P. Kater, George F. Widhopf, Carlo M. Croce, Michael Karin y Thomas J. Kipps. "Constitutive Baff Signalling Plays a Key Role in CLL Development by Promoting Tumor Cell Survival". Blood 112, n.º 11 (16 de noviembre de 2008): 28. http://dx.doi.org/10.1182/blood.v112.11.28.28.
Texto completoGobessi, Stefania, Sara Bennardo, Pablo G. Longo, Brendan Doe y Dimitar G. Efremov. "Development of a Transgenic Mouse Model to Study the Role of ZAP-70 in the Development and Progression of Chronic Lymphocytic Leukemia". Blood 118, n.º 21 (18 de noviembre de 2011): 2830. http://dx.doi.org/10.1182/blood.v118.21.2830.2830.
Texto completoLee, Avery C., Sai R. Pingali, Javier A. Pinilla-Ibarz, Chih-Hang A. Tang y Chih-Chi A. Hu. "Abstract 142: Loss of AID exacerbates the malignant progression of CLL". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 142. http://dx.doi.org/10.1158/1538-7445.am2022-142.
Texto completoBondada, Subbarao, James P. Collard, Mary Kathryn McKenna, Sunil K. Noothi, Sara S. Alhakeem, Jacqueline R. Rivas y Shelbi Broeking. "The role of the splenic microenvironment in Chronic Lymphocytic Leukemia". Journal of Immunology 204, n.º 1_Supplement (1 de mayo de 2020): 163.6. http://dx.doi.org/10.4049/jimmunol.204.supp.163.6.
Texto completoMärklin, Melanie, Stefanie Bugl, Jonas S. Heitmann, Alexandra Poljak, Bettina S, Hans-Georg Kopp, Lothar Kanz, Anjana Rao, Stefan Wirths y Martin R. Müller. "Genetic Loss of NFAT2 Induces Profound Acceleration of CLL in the TCL1 Mouse Model". Blood 120, n.º 21 (16 de noviembre de 2012): 862. http://dx.doi.org/10.1182/blood.v120.21.862.862.
Texto completoMcKenna, Mary Kathryn, Sunil K. Noothi, Sara Samir Alhakeem, John C. Byrd, Natarajan Muthusamy, Vivek Rangnekar y Subbarao Bondada. "Splenic microenvironment is important in the survival and growth of Chronic Lymphocytic Leukemia in mice". Journal of Immunology 198, n.º 1_Supplement (1 de mayo de 2017): 130.20. http://dx.doi.org/10.4049/jimmunol.198.supp.130.20.
Texto completoWoyach, Jennifer A., Matthew R. Stefanovski, Virginia Goettl, Amy S. Ruppert, Kelly A. Smucker, Lisa L. Smith, Jason A. Dubovsky et al. "Global Inhibition of Bruton's Tyrosine Kinase (BTK) Delays the Development and Expansion of Chronic Lymphocytic Leukemia (CLL) in the TCL1 Mouse Model of Disease". Blood 120, n.º 21 (16 de noviembre de 2012): 183. http://dx.doi.org/10.1182/blood.v120.21.183.183.
Texto completoSchrage, Matthew I., David Kim, Jeffrey Calimlim, Evelena Ontiveros, Michael A. Teitell, Jonathan W. Said y Sven de Vos. "The PIM1 Oncogene Accelerates TCL1 Driven Lymphomagenesis in a Double-Transgenic Murine Model." Blood 112, n.º 11 (16 de noviembre de 2008): 1806. http://dx.doi.org/10.1182/blood.v112.11.1806.1806.
Texto completoMinden, Marcus Dühren-von, Thomas Wossning, Hassan Jumaa y Hendrik Veelken. "The Role of the BCR Class Expressed by Eμ-TCL1tg Mice and Human CLL". Blood 120, n.º 21 (16 de noviembre de 2012): 182. http://dx.doi.org/10.1182/blood.v120.21.182.182.
Texto completoMotiwala, Tasneem, Nicola Zanesi, Jharna Datta, Satavisha Roy, Huban Kutay, Allyn M. Checovich, Mohamed Kaou et al. "AP-1 elements and TCL1 protein regulate expression of the gene encoding protein tyrosine phosphatase PTPROt in leukemia". Blood 118, n.º 23 (1 de diciembre de 2011): 6132–40. http://dx.doi.org/10.1182/blood-2011-01-323147.
Texto completoHertlein, Erin K., Timothy L. Chen, David M. Lucas, Nikhil Gupta, Jessica MacMurray, Virginia M. Goettl, Amy M. Lehman, Amy J. Johnson y John C. Byrd. "NFkB p50 (Nfkb1) Contributes to Disease in the Eu-TCL1 Mouse Model of Chronic Lymphocytic Leukemia". Blood 126, n.º 23 (3 de diciembre de 2015): 1248. http://dx.doi.org/10.1182/blood.v126.23.1248.1248.
Texto completoAlhakeem, Sara, Mary McKenna, Beth Gachuki, Chi Wang, Jinpeng Liu, John Byrd, Natarajan Muthusamy y Subbarao Bondada. "Constitutive IL-10 production by normal and malignant B-1 cells is dependent on B cell receptor signaling (IRM10P.620)". Journal of Immunology 194, n.º 1_Supplement (1 de mayo de 2015): 131.18. http://dx.doi.org/10.4049/jimmunol.194.supp.131.18.
Texto completoDong, Shuai, John C. Byrd y Amy J. Johnson. "Genetic Inhibition of PI3K p110delta Antagonizes Survival Signals and Induces Immune Activation in Chronic Lymphocytic Leukemia (CLL)". Blood 126, n.º 23 (3 de diciembre de 2015): 1711. http://dx.doi.org/10.1182/blood.v126.23.1711.1711.
Texto completoOntiveros, Evelena, David Dae-Young Kim, Jeffrey M. Calimlim, Matthew I. Schrage, Quang T. Luong, Debra Tosity, Bao Ngan Doan et al. "The PIM1 Oncogene Accelerates TCL1 Driven Lymphomagenesis in a Double-Transgenic Murine Model." Blood 114, n.º 22 (20 de noviembre de 2009): 2968. http://dx.doi.org/10.1182/blood.v114.22.2968.2968.
Texto completoSuljagic, Mirza, Pablo G. Longo, Luca Laurenti y Dimitar G. Efremov. "The Syk Inhibitor R788 (FosD) Inhibits Tumor Growth in the TCL1 Transgenic Mouse Model of CLL by Blocking Antigen-Dependent BCR Signaling." Blood 114, n.º 22 (20 de noviembre de 2009): 887. http://dx.doi.org/10.1182/blood.v114.22.887.887.
Texto completoRößner, Philipp M., Bola S. Hanna, Thorsten Zenz, Stephan Stilgenbauer, Peter Lichter y Martina Seiffert. "The role of CXCR3 in the microenvironment of chronic lymphocytic leukemia". Journal of Immunology 196, n.º 1_Supplement (1 de mayo de 2016): 73.12. http://dx.doi.org/10.4049/jimmunol.196.supp.73.12.
Texto completoSchulze-Edinghausen, Lena, Claudia Dürr, Selcen Öztürk, Manuela Zucknick, Axel Benner, Verena Kalter, Sibylle Ohl et al. "Dissecting the Prognostic Significance and Functional Role of Progranulin in Chronic Lymphocytic Leukemia". Cancers 11, n.º 6 (13 de junio de 2019): 822. http://dx.doi.org/10.3390/cancers11060822.
Texto completoChen, Shih-Shih, Rainer Claus, David M. Lucas, Lianbo Yu, Jiang Qian, Amy S. Ruppert, Derek A. West et al. "Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLL". Blood 117, n.º 3 (20 de enero de 2011): 862–71. http://dx.doi.org/10.1182/blood-2010-05-284638.
Texto completoLapalombella, Rosa, Virginia Goettl, Katie Williams, Larissa Tangeman, Shruti Jha, Jason A. Dubovsky, Danielle L. Chappell et al. "Significant in Vivo Efficacy of the SINE KPT-330 in Mouse Models of CLL." Blood 120, n.º 21 (16 de noviembre de 2012): 2452. http://dx.doi.org/10.1182/blood.v120.21.2452.2452.
Texto completoMaharaj, Kamira, John J. Powers, Alex Achille, Melanie Mediavilla-Varela, Wael Gamal, Karen L. Burger, Renee Fonseca et al. "The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells". Blood Advances 4, n.º 13 (7 de julio de 2020): 3072–84. http://dx.doi.org/10.1182/bloodadvances.2020001800.
Texto completoWidhopf, George F., Bing Cui, Esther Avery, George Chen, Masato Obara, Karen Messer y Thomas J. Kipps. "ROR1 Expression Accelerates Leukemia Development in RORxTCL1 Transgenic Mice",. Blood 118, n.º 21 (18 de noviembre de 2011): 3905. http://dx.doi.org/10.1182/blood.v118.21.3905.3905.
Texto completoHayakawa, Kyoko, Anthony M. Formica, Joni Brill-Dashoff, Susan A. Shinton, Daiju Ichikawa, Yan Zhou, Herbert C. Morse y Richard R. Hardy. "Early generated B1 B cells with restricted BCRs become chronic lymphocytic leukemia with continued c-Myc and low Bmf expression". Journal of Experimental Medicine 213, n.º 13 (29 de noviembre de 2016): 3007–24. http://dx.doi.org/10.1084/jem.20160712.
Texto completoRattmann, Ina, David Zhu, Carlo M. Croce, John C. Byrd, Yi Gu, Thomas Moritz y David A. Williams. "The Expression of the GTPase-Deficient, Hematopoietic-Specific RhoH GTPase Is Implicated in Development of Chronic Lymphocytic Leukemia (CLL)." Blood 110, n.º 11 (16 de noviembre de 2007): 339. http://dx.doi.org/10.1182/blood.v110.11.339.339.
Texto completoEgle, Alexander, Josefina D. Pinon, Christoph Heyder, Claudia Holler, Ursula Denk, Inge Tinhofer y Richard Greil. "T Cell Dynamics during the Pretumor and Tumor Phase in the Murine Tcl1 Transgenic Chronic Lymphocytic Leukemia Model". Blood 112, n.º 11 (16 de noviembre de 2008): 3145. http://dx.doi.org/10.1182/blood.v112.11.3145.3145.
Texto completoGhia, Paolo, Maria TS Bertilaccio, Cristina Scielzo, Giorgia Simonetti, Benedetta Apollonio, Claudia Fazi, Marta Muzio, Maurilio Ponzoni y Federico Caligaris-Cappio. "Novel Mouse Models of Chronic Lymphocytic Leukemia (CLL) Unravel the Molecular Mechanisms Controlling Bone Marrow Involvement by Leukemic B Cells." Blood 114, n.º 22 (20 de noviembre de 2009): 360. http://dx.doi.org/10.1182/blood.v114.22.360.360.
Texto completoPapait, Andrea, Tiziana Vaisitti, Sara Serra, Valentina Audrito, Francesco Tito, Giulia Guerra, Dimitar G. Efremov y Silvia Deaglio. "Targeting the Adenosinergic Axis in the Eμ-TCL1 Chronic Lymphocytic Leukemia Mouse Model Offers Novel Therapeutic Opportunities". Blood 132, Supplement 1 (29 de noviembre de 2018): 240. http://dx.doi.org/10.1182/blood-2018-99-118057.
Texto completoZanesi, Nicola, Rami Aqeilan, Alessandra Drusco, Mohamed Kaou, Cinzia Sevignani, Stefan Costinean, Laura Bortesi et al. "Effect of Rapamycin on Mouse Chronic Lymphocytic Leukemia and the Development of Nonhematopoietic Malignancies in Eμ-TCL1 Transgenic Mice". Cancer Research 66, n.º 2 (15 de enero de 2006): 915–20. http://dx.doi.org/10.1158/0008-5472.can-05-3426.
Texto completoRivas, Jacqueline R., Sara S. Alhakeem, Joseph M. Eckenrode, Yinan Zhang, James P. Collard, Gerhard C. Hildebrandt, Roger A. Fleischman et al. "Enhancing Anti-Tumor Immunity and Responses to Immune Checkpoint Blockade By Suppressing Interleukin-10 in Chronic Lymphocytic Leukemia". Blood 134, Supplement_1 (13 de noviembre de 2019): 5486. http://dx.doi.org/10.1182/blood-2019-127178.
Texto completoRassenti, Laura, L. Huynh, G. W. Basak, E. M. Ghia, D. Van Dyke, N. Heerema, D. Zahrieh et al. "TCL1 Expression in Chronic Lymphocytic Leukemia Correlates with the Intensity of 11q Deletions and ZAP-70." Blood 110, n.º 11 (16 de noviembre de 2007): 2068. http://dx.doi.org/10.1182/blood.v110.11.2068.2068.
Texto completoWu, Qing-Li, Claudia Zierold y Erik A. Ranheim. "Dysregulation of Frizzled 6 is a critical component of B-cell leukemogenesis in a mouse model of chronic lymphocytic leukemia". Blood 113, n.º 13 (26 de marzo de 2009): 3031–39. http://dx.doi.org/10.1182/blood-2008-06-163303.
Texto completoYan, Xiao-Jie, Pablo Morande, Ezra B. Kolitz, Crystal D. Grant, Gautam Nayyar, Pablo Oppezzo y Nicholas Chiorazzi. "Overexpression of Activation-Induced Deaminase in TCL1 Mice Leads to the Development of IGHV -Mutated and -Unmutated CLL Clones That Resemble Unique Subsets of Human CLL". Blood 126, n.º 23 (3 de diciembre de 2015): 1710. http://dx.doi.org/10.1182/blood.v126.23.1710.1710.
Texto completoYan, Xiao J., Emilia Albesiano, Gloria Telusma, Nicola Zanesi, Carlo M. Croce y Nicholas Chiorazzi. "The BCRs Expressed by Leukemia Cells from TCL1 Transgenic Mice Resemble Those of Unmutated B-CLL." Blood 106, n.º 11 (16 de noviembre de 2005): 49. http://dx.doi.org/10.1182/blood.v106.11.49.49.
Texto completo